Skip to main content
. 2024 Oct 2;17:194. doi: 10.1186/s13048-024-01520-2

Fig. 5.

Fig. 5

Drug sensitivity compatibility between PDOs and clinical data. Summary timeline of the platinum-sensitive (HGSC-4, A), resistant (EM-2, B), and refractory (HGSC-5, C; CCC-2 D) treatment plans. The reference range of CA 125 is 0–35 units/mL. Circle with straight lines indicates the time of sample collection